首页 > 市场调查报告书 > 医疗设备

体外诊断人工智能诊断用人工智能

市场调查报告书

商品编码

1741351

人工智慧（AI）诊断市场（按组件、诊断类型和地区）

Artificial Intelligence Diagnostics Market, By Component, By Diagnostics Type, By Region

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

人工智慧 (AI) 诊断市场在 2025 年的价值估计为 22.078 亿美元，预计到 2032 年将达到 84.816 亿美元，2025 年至 2032 年的复合年增长率为 21.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	22.078亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	21.20%	2032年价值预测	84.816亿美元

人工智慧 (AI) 在医疗保健领域拥有巨大潜力，它能够快速深入地分析大量数据。在体外诊断 (IVD) 等领域，这可能会带来变革性的影响。正因如此，医疗保健领域对人工智慧技术的需求日益增长。

市场动态：

随着人工智慧 (AI) 的发展和应用，医学诊断实践正在迅速改变。随着电脑处理能力的不断提升，基于 AI 的系统如今能够为各个专业领域提供精准高效的诊断和治疗管理方案。由于计算能力、学习演算法、云端储存以及电子健康记录资料集可用性等方面的进步，AI 将在诊断和医疗保健领域发挥重要作用。 AI 将使放射科医生和病理学家能够在早期准确诊断病情，从而提供适当有效的治疗。

2017 年 12 月的一篇关于人工智慧在放射学研究中的应用的 PubMed 论文指出，下一个突破不是来自创新的放射学设备，而是来自人工智慧的整合。这种整合可能会分阶段进行。基于人工智慧的设备从超音波、MRI、CT 和 PET 等影像技术中收集数据。作为第一步，人工智慧已经对各种影像资料和结构进行自动分割，提供了重要的分析价值并帮助放射科医生缩短时间。在未来十年，基于人工智慧的放射学解决方案可能会用于在放射科医生进行分析之前执行量化、分割和模式识别等常规任务，从而改善患者照护的服务。

本研究的主要特点

本报告对全球人工智慧 (AI) 诊断市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025-2032 的市场规模和复合年增长率。
它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球人工智慧 (AI) 诊断市场的主要企业会根据以下参数进行分析，例如公司亮点、产品系列、关键亮点、财务表现和策略。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球人工智慧 (AI) 诊断市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球人工智慧 (AI) 诊断市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2,207.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	21.20%	2032 Value Projection:	USD 8,481.6 Mn

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

Global Artificial Intelligence Diagnostics Market, By Component:
- Software
- Hardware
- Services
Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
- Cardiology
- Oncology
- Pathology
- Radiology
- Neurology
- Others
Global Artificial Intelligence Diagnostics Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Vuno Inc.
- CHC Healthcare Group
- Aidoc
- Imbio
- Alivecor Inc.
- Digital Diagnostics
- Retina AI
- Canon Medical Systems USA
- Healthy IO
- Milliman Inc.
- GE Healthcare
- Arterys
- Alivecor Inc.
- Riverain
- Lucid Health
- Qure.AI
- Cardiologs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Service Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising incidence of infectious diseases
- Concerns about the use of thermometers
- High demand for Artificial Intelligence (AI) diagnostics devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Artificial Intelligence (AI) Diagnostics Market, By Component, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnostics Market, By Diagnostics Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pathology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Radiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnostics Market, By Geography, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)

8. Competitive Landscape

Vuno Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CHC Healthcare Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aidoc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Imbio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Digital Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Retina AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems USA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Healthy IO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Milliman Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arterys
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Riverain
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lucid Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qure.AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiologs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

人工智慧（AI）诊断市场（按组件、诊断类型和地区）